back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2018-08-23 Tx date 2018-08-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$20,000
+400,000 vol $0.05 each |
1,750,000 | |
| Filed 2018-08-23 Tx date 2018-08-22 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+400,000 vol $0.075 each |
1,350,000 | |
| Filed 2018-04-09 Tx date 2018-04-06 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$13,000
+200,000 vol $0.065 each |
2,700,000 | |
| Filed 2017-01-24 Tx date 2017-01-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+150,000 vol |
2,500,000 | |
| Filed 2016-10-31 Tx date 2016-10-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+600,000 vol |
950,000 | |
| Filed 2016-10-31 Tx date 2016-10-28 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$30,000
+600,000 vol $0.05 each |
1,350,000 | |
| Filed 2016-05-19 Tx date 2016-05-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
53 - Grant of warrants
|
+350,000 vol |
350,000 | |
| Filed 2016-05-19 Tx date 2007-02-23 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2016-05-19 Tx date 2016-05-19 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
16 - Acquisition or disposition under a prospectus exemption
|
$35,000
+700,000 vol $0.05 each |
750,000 | |
| Filed 2015-12-30 Tx date 2015-12-29 |
$APC
Advanced Proteome Therapeutics Corporation |
Krantz, Alexander (Allen)
4 - Director of Issuer, 5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+125,000 vol |
2,350,000 |